Abstract |
A long-term, multi-centre open study was carried out to evaluate the efficacy, cycle control and side-effects with a triphasic, combined oral contraceptive containing levonorgestrel and ethinyloestradiol (' Trinordiol'). A total of 2517 women completing at least 1 cycle of treatment was followed up at 2 to 3-monthly intervals; the overall number of cycles on treatment was 37,090. During treatment, only 2 pregnancies occurred which were attributable to pill failure. Cycle control was good: cycle irregularities were 9.6% overall, but were most common (19.6%) during the first 3 cycles. Only 3.8% of patients withdrew from the study for this reason. Side-effects were those commonly seen with oral contraceptives, and they produced a drop-out rate of only 13.9%. There were no clinically significant effects on blood pressure or body weight. The results also suggested that ' Trinordiol' has a beneficial effect on pre-existing acne.
|
Authors | A J Butler, A Green, M Cohen |
Journal | Current medical research and opinion
(Curr Med Res Opin)
Vol. 10
Issue 8
Pg. 503-13
( 1987)
ISSN: 0300-7995 [Print] England |
PMID | 2960493
(Publication Type: Journal Article)
|
Chemical References |
- Contraceptives, Oral, Combined
- Contraceptives, Oral, Sequential
- Norgestrel
- Ethinyl Estradiol
- Ethinyl Estradiol-Norgestrel Combination
|
Topics |
- Acne Vulgaris
(drug therapy)
- Adolescent
- Adult
- Blood Pressure
(drug effects)
- Body Weight
(drug effects)
- Contraceptives, Oral, Combined
(adverse effects)
- Contraceptives, Oral, Sequential
(adverse effects)
- Ethinyl Estradiol
(administration & dosage, adverse effects, pharmacology)
- Ethinyl Estradiol-Norgestrel Combination
- Female
- Follow-Up Studies
- Humans
- Menstrual Cycle
(drug effects)
- Norgestrel
(administration & dosage, adverse effects, pharmacology)
|